Results 11 to 20 of about 59,855 (258)
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia [PDF]
, Stewart A Factor, Paul M Ramirez
exaly +3 more sources
ABSTRACT— Tardive dyskinesia (TD) is a syndrome of involuntary movements that develops in predisposed individuals during neuroleptic drug treatment, with an average prevalence of 15%. Neuroleptic (antidopaminergic) drugs are the predominant etiological factor.
J Gerlach, D E Casey, D E Casey
exaly +7 more sources
Tardive dyskinesia is a group of hyperkinetic and hypokinetic movement disorders, following the administration of dopamine receptor-blocking drugs. The severity of these syndromes varies from soft forms to the development of life-degrading situations ...
Violetta A. Tolmacheva
doaj +2 more sources
The use of clozapine and clonazepam co-administration in the treatment of a severe tardive dyskinesia: A case report [PDF]
This is a case report of a patient who was treated with clozapine and clonazepam after he developed neuroleptic-induced tardive dyskinesia following treatment for schizophrenia.
Kibrom Haile, Halima Umer
doaj +2 more sources
Refractory tardive dyskinesia in the critical care setting: A case report of successful use of phenobarbital [PDF]
Tardive dyskinesia is a hyperkinetic movement disorder most often induced by chronic antipsychotic use. It can be challenging to treat, particularly when symptoms persist despite standard therapies such as vesicular monoamine transporter 2 inhibitors. We
Abdelrahman S. Abdalla +4 more
doaj +2 more sources
Paliperidone ER-induced tardive dyskinesia
The evidence suggests a lower tardive dyskinesia risk associated with atypical antipsychotics. We present two adult female cases with tardive dyskinesia.
Omer Yanartas +4 more
doaj +3 more sources
Objectives: An established theory for the pathogenesis of tardive dyskinesia is disturbed dopaminergic receptor sensitivity and/or dopaminergic intracellular signaling.
Svetlana A Ivanova +12 more
doaj +2 more sources
Co‐Expression of Tardive Dyskinesia and Drug‐Induced Parkinsonism in Rats Chronically Treated With Haloperidol [PDF]
Aim We aimed to create a rat model of drug‐induced parkinsonism and tardive dyskinesia by chronic administration of haloperidol and examine the expression of direct and indirect pathway markers in the striatum of the model rats.
Iku Kinoshita +7 more
doaj +2 more sources
Patient and physician perceptions of the burden of tardive dyskinesia: an international survey [PDF]
Craig Chepke +10 more
openalex +2 more sources
Pathophysiology, prognosis and treatment of tardive dyskinesia
Tardive dyskinesia (TD), a movement disorder associated with antipsychotics, most frequently affects the lower face and jaw muscles, but can also affect walking, breathing and use of the hands and limbs.
H. Takeuchi, Yasuhiro Mori, Y. Tsutsumi
semanticscholar +1 more source

